Allarity Therapeutics ALLR
NASDAQ ALLR
$1.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Cash & Equivalents (2020 - 2026)

Updated

Allarity Therapeutics (ALLR) reported Cash & Equivalents of $16.98 million for Q2 2026, down 4.6% from $17.8 million a year earlier and down 14.3% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Allarity Therapeutics posted Cash & Equivalents of $14.69 million, down 24.8% from FY2024.

  • Cash & Equivalents has a five-year compound annual growth rate of 118.0% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $19.53 million in FY2024, $166,000 in FY2023 (-91.8%), $2.03 million in FY2022 (-89.6%) and $19.56 million in FY2021.
  • Five-year quarterly Cash & Equivalents spans a low of $166,000 in Q4 2023 and a high of $25.2 million in Q1 2025.
  • Year over year, Cash & Equivalents has now declined in each of the last three quarters, with an average decline of 14.6% over the last four quarters.
  • The high point for year-over-year Cash & Equivalents in five years was Q2 2022 (growth of 16.4%); the low point was Q1 2023 (a decline of 98.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $19.81 million (Q1 2026), $14.69 million (Q4 2025) and $16.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Allarity Therapeutics 1.67 Mn 1.67 Mn - 16.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.98 Mn
Mar 31, 2026 19.81 Mn
Dec 31, 2025 14.69 Mn
Sep 30, 2025 16.90 Mn
Jun 30, 2025 17.80 Mn
Mar 31, 2025 25.20 Mn
Dec 31, 2024 19.53 Mn
Jun 30, 2024 19.23 Mn
Mar 31, 2024 312,000.00
Dec 31, 2023 166,000.00
Sep 30, 2023 1.40 Mn
Jun 30, 2023 420,000.00
Mar 31, 2023 295,000.00
Dec 31, 2022 2.03 Mn
Sep 30, 2022 3.95 Mn
Jun 30, 2022 7.68 Mn
Mar 31, 2022 14.54 Mn
Dec 31, 2021 19.56 Mn
Sep 30, 2021 5.58 Mn
Jun 30, 2021 6.60 Mn
API Access

Allarity Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALLR&period=max&api_key=YOUR_API_KEY